|

DisitamabVedotinForIicction Toripalimab Clinical Trials

1 actively recruiting trial

Also known as: radical cystectomy

Pipeline

Phase 1/2: 1

Top Sponsors

  • Zhujiang Hospital1

Indications

  • Muscle-Invasive Bladder Carcinoma1
  • Bladder Cancer1
  • Cancer1

Other1 trial

RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.